421 related articles for article (PubMed ID: 31539122)
1. Long non-coding RNA MEG3 represses cholangiocarcinoma by regulating miR-361-5p/TRAF3 axis.
Lu WX
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7356-7368. PubMed ID: 31539122
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOTAIR suppresses cell apoptosis, autophagy and induces cell proliferation in cholangiocarcinoma by modulating the miR-204-5p/HMGB1 axis.
Lu M; Qin X; Zhou Y; Li G; Liu Z; Yue H; Geng X
Biomed Pharmacother; 2020 Oct; 130():110566. PubMed ID: 32755793
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
[TBL] [Abstract][Full Text] [Related]
4. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.
Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y
Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691
[TBL] [Abstract][Full Text] [Related]
5. LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis.
Du H; Hou S; Zhang L; Liu C; Yu T; Zhang W
Aging (Albany NY); 2023 May; 15(9):3759-3770. PubMed ID: 37166421
[TBL] [Abstract][Full Text] [Related]
6. CircSETD3 (hsa_circ_0000567) inhibits proliferation and induces apoptosis in cholangiocarcinoma cells via downregulation of microRNA-421 expression.
Xiong W; Zhang A; Xiao X; Liu W
Bioengineered; 2022 Apr; 13(4):10191-10201. PubMed ID: 35435120
[TBL] [Abstract][Full Text] [Related]
7. lncRNA SNHG16 Mediates Cell Proliferation and Apoptosis in Cholangiocarcinoma by Directly Targeting miR-146a-5p/GATA6 Axis.
Wu T; Lei MS; Gao XZ; Xiong TG; Yang K; Gong Q; Tang R; Tian YP; Fu XH
Biochem Genet; 2021 Oct; 59(5):1311-1325. PubMed ID: 33797690
[TBL] [Abstract][Full Text] [Related]
8. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
[TBL] [Abstract][Full Text] [Related]
10. LncRNA DANCR affected cell growth, EMT and angiogenesis by sponging miR-345-5p through modulating Twist1 in cholangiocarcinoma.
Zhu CY; Fan CR; Zhang YL; Sun QX; Yan MJ; Wei W; Liu GF; Liu JJ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2321-2334. PubMed ID: 32196584
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR-296-5p.
Li Z; Jiang X; Huang L; Li J; Ji D; Xu Y; Leng K; Cui Y
J Cell Mol Med; 2019 Dec; 23(12):8258-8268. PubMed ID: 31565837
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MEG3 Participates in Caerulein-Induced Inflammatory Injury in Human Pancreatic Cells via Regulating miR-195-5p/FGFR2 Axis and Inactivating NF-κB Pathway.
Chen X; Song D
Inflammation; 2021 Feb; 44(1):160-173. PubMed ID: 32856219
[TBL] [Abstract][Full Text] [Related]
13. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma.
Li O; Jiang B; Yi WM; Zhang Y; Yang PZ; Guo C; Sun ZP; Peng C
Kaohsiung J Med Sci; 2021 May; 37(5):379-391. PubMed ID: 33502823
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR-551b-3p/CCND1 axis.
Chang W; Wang Y; Li W; Geng Z
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1067-1075. PubMed ID: 32064660
[TBL] [Abstract][Full Text] [Related]
15. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
Liu Z; Chen JY; Zhong Y; Xie L; Li JS
Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
[TBL] [Abstract][Full Text] [Related]
16. LINC01410 promotes cell proliferation and migration of cholangiocarcinoma through modulating miR-124-3p/SMAD5 axis.
Jiang T; Wang C; Zhu Y; Han H
J Gene Med; 2020 Jun; 22(6):e3162. PubMed ID: 31951299
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG3 Facilitates the Malignant Phenotype of Cholangiocarcinoma Cells via the miR-3173-5p/ERG Axis.
Sun ZP; Tan ZG; Peng C; Yi WM
J Gastrointest Surg; 2022 Apr; 26(4):802-812. PubMed ID: 34647226
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of PVT1 inhibits IL-1β-induced injury in chondrocytes by regulating miR-27b-3p/TRAF3 axis.
Lu X; Yu Y; Yin F; Yang C; Li B; Lin J; Yu H
Int Immunopharmacol; 2020 Feb; 79():106052. PubMed ID: 31863917
[TBL] [Abstract][Full Text] [Related]
19. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
Wang L; Yu M; Zhao S
J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
[TBL] [Abstract][Full Text] [Related]
20. LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma.
Zhang L; Jiang G; Lu J; Wang L
Clin Transl Oncol; 2024 Feb; 26(2):414-423. PubMed ID: 37400667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
